Stemi clinical trials

Explore recruiting stemi clinical trials.

Recruiting stemi studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stemi trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IOCYTE AMI-3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intravenous FDY-5301 in Patients with an Anterior ST-Elevation Myocardial Infarction

Portugal, Czechia, Spain, Slovakia, Hungary, Netherlands +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2, Multicenter, Randomized, Parallel, 3-arm, Placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤ 45%) After Myocardial Infarction (HF-REVERT)

Poland, Spain, Czechia, Greece, Netherlands, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

AMUNDSEN - Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI), and randomized to Subcutaneous Evolocumab or Normal strategies to reach guidelines LDL objectives in the real-world - The AMUNDSEN-real trial-

Spain, Germany, Poland, France, Italy

Therapeutic use (Phase IV) EU CTIS Study details

Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI: an open label randomized controlled multicenter Phase-II study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Masked, Multicentre, Placebo-controlled, Randomized Phase IIa Clinical Trial to investigate the safety and efficacy of ApTOLL in a population of ST Elevation Myocardial Infarct (STEMI) patients.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs tAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascularization.

Germany, Netherlands, Italy, Belgium, Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Stemi trials by city

Stemi in Toronto Stemi in Vancouver Stemi in Montreal Stemi in Calgary Stemi in Edmonton Stemi in Ottawa Stemi in Winnipeg Stemi in Quebec City Stemi in Hamilton Stemi in Kitchener Stemi in London Stemi in Halifax Stemi in New York Stemi in Los Angeles Stemi in Chicago Stemi in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease